(ARKG) ARK Genomic Revolution - Performance -5.2% in 12m
Compare ARKG with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-54.43%
#44 in Group
Rel. Strength
38.14%
#4964 in Universe
Total Return 12m
-5.15%
#35 in Group
Total Return 5y
-45.68%
#44 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ARKG (-5.2%) vs SPY (9.5%)

5y Drawdown (Underwater) Chart

Top Performers in Health
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
PPH NASDAQ VanEck Pharmaceutical |
-6.49% | 1.56% | 53.6% | - | - | - | - | - |
IHE NYSE ARCA iShares U.S. |
-6.84% | 5.81% | 39.2% | - | - | - | - | - |
XLV NYSE ARCA Health Care Sector SPDR |
-6.63% | -0.89% | 46.3% | - | - | - | - | - |
IYH NYSE ARCA iShares U.S. Healthcare |
-7.02% | -1.87% | 40.2% | - | - | - | - | - |
VHT NYSE ARCA Vanguard Health Care |
-6.7% | -1.2% | 39.7% | - | - | - | - | - |
FHLC NYSE ARCA Fidelity MSCI Health Care |
-6.75% | -1.32% | 39.2% | - | - | - | - | - |
IHI NYSE ARCA iShares U.S. Medical |
-2.08% | 6.95% | 38.3% | - | - | - | - | - |
IXJ NYSE ARCA iShares Global Healthcare |
-5.58% | -1.16% | 34.6% | - | - | - | - | - |
Performance Comparison: ARKG vs SPY vs S&P 500
SPY (SPDR SP500 Trust ETF) is the Sector Benchmark for ARKG
Total Return (including Dividends) | ARKG | SPY | S&P 500 |
---|---|---|---|
1 Month | -6.81% | -4.77% | -4.77% |
3 Months | -17.10% | -9.81% | -9.81% |
12 Months | -5.15% | 9.54% | 9.54% |
5 Years | -45.68% | 104.83% | 104.83% |
Trend Score (consistency of price movement) | ARKG | SPY | S&P 500 |
1 Month | 7.00% | -51.2% | -51.2% |
3 Months | -88.4% | -90.1% | -90.1% |
12 Months | -27.4% | 59.4% | 59.4% |
5 Years | -89.5% | 84.2% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. SPY | vs. S&P 500 |
1 Month | #28 | -2.14% | -2.14% |
3 Month | #44 | -8.08% | -8.08% |
12 Month | #39 | -13.4% | -13.4% |
5 Years | #43 | -73.5% | -73.5% |
FAQs
Does ARKG ARK Genomic Revolution outperforms the market?
No,
over the last 12 months ARKG made -5.15%, while its related Sector, the SPDR SP500 Trust (SPY) made 9.54%.
Over the last 3 months ARKG made -17.10%, while SPY made -9.81%.
Over the last 3 months ARKG made -17.10%, while SPY made -9.81%.
Performance Comparison ARKG vs Indeces and Sectors
ARKG vs. Indices ARKG is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.76% | -2.04% | 1.41% | -14.7% |
US NASDAQ 100 | QQQ | 3.37% | -2.06% | 1.17% | -15.4% |
US Dow Jones Industrial 30 | DIA | 6.15% | -1.10% | 1.03% | -11.1% |
German DAX 40 | DAX | 4.44% | -3.40% | -17.0% | -26.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 6.77% | -3.72% | 1.10% | -14.7% |
Hongkong Hang Seng | HSI | 4.11% | -3.60% | -1.51% | -20.7% |
India NIFTY 50 | INDA | 5.78% | -9.92% | -1.30% | -9.22% |
Brasil Bovespa | EWZ | 2.58% | -8.91% | -2.33% | 1.59% |
ARKG vs. Sectors ARKG is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.66% | -1.82% | -7.66% | -22.5% |
Consumer Discretionary | XLY | 3.91% | -1.83% | -1.03% | -17.6% |
Consumer Staples | XLP | 9.61% | -8.89% | -4.05% | -14.7% |
Energy | XLE | 7.33% | 4.29% | 2.98% | 6.22% |
Financial | XLF | 5.18% | -3.02% | -6.75% | -24.3% |
Health Care | XLV | 7.21% | -0.18% | 3.66% | -4.26% |
Industrial | XLI | 5.64% | -2.89% | 0.58% | -12.4% |
Materials | XLB | 5.53% | -3.00% | 7.48% | -1.20% |
Real Estate | XLRE | 8.26% | -3.87% | 3.44% | -19.8% |
Technology | XLK | 2.09% | -1.20% | 6.42% | -9.61% |
Utilities | XLU | 7.74% | -7.17% | -1.25% | -26.3% |
Aerospace & Defense | XAR | 5.51% | -6.19% | -9.93% | -30.8% |
Biotech | XBI | 2.08% | 2.12% | 13.2% | -1.66% |
Homebuilder | XHB | 4.76% | -0.98% | 16.2% | 2.24% |
Retail | XRT | 5.66% | -2.98% | 5.13% | -1.09% |